Is Core Stock Worth Buying After a 27% Surge in 6 Months?

In This Article:

Core Laboratories Inc. CLB, an oilfield services company, operates in more than 50 countries and specializes in reservoir management and production enhancement. Its shares have risen 26.9% in the past six months, outperforming the broader oil and energy sector's  1.3% growth. The stock has also surpassed the Field Services sub-industry and competitors like TechnipFMC FTI, which gained 15.5%, Halliburton HAL and Liberty Energy LBRT, which fell 11.6% and 13%, respectively.

 

6-Month Price Performance Comparison

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

With the CLB stock gaining attention due to its strong performance, many investors are curious about what is contributing to the company’s results and if it is a good time to invest. Let us take a closer look at the factors driving the stock and consider any potential risks.

 

What is Favoring the CLB Stock?

Strong Growth in International Business: CLB’s Reservoir Description segment continues to benefit from international and offshore drilling activity, with approximately 80% of revenues originating outside the United States. Despite headwinds from reduced U.S. land activity and geopolitical disruptions, CLB has successfully expanded its global presence, particularly in the Middle East. Its laboratory capabilities and advanced reservoir evaluation technologies have positioned CLB as a key partner for national oil companies and major operators.

The increasing focus on offshore developments in regions such as the South Atlantic Margin, North and West Africa, Norway and Asia Pacific presents a significant opportunity for sustained revenue growth.

Robust Free Cash Flow Supports Shareholder Value: One of CLB’s major strengths is its ability to generate strong free cash flow (“FCF”). In 2024, the company delivered $43.4 million in FCF, a 200% increase year over year, despite facing industry headwinds.

Core Laboratories Inc.
Core Laboratories Inc.


Image Source: Core Laboratories Inc.

This growth in FCF enables the company to fund share buybacks, pay dividends, and reinvest in technology and innovation without requiring excessive borrowing. The company remains committed to maintaining an asset-light model that ensures predictable cash flow and returns to shareholders.

Expansion of Proprietary Technologies: CLB is at the forefront of reservoir evaluation technology, with proprietary innovations such as Nuclear Magnetic Resonance (“NMR”) technology and FlowProfiler tracers. These technologies allow operators to differentiate between movable and immovable hydrocarbons, improving hydrocarbon recovery and optimizing well performance. The company’s continued investment in advanced diagnostic tools for completions and reservoir characterization provides a significant competitive advantage in the energy sector.